436 Results for "

SRC

" in MedChemExpress (MCE) Product Catalog:
Products (436)

436 Results for "SRC" in MCE Product Catalog:

Cat. No.: HY-P811965
Synonyms: CIN85, SH3KBP1, SH3 domain-containing kinase-binding protein 1, CD2-binding protein 3, Cbl-interacting protein of 85 kDa, Human SRC family kinase-binding protein 1, CD2BP3, HSB-1

Host:  

Mouse

Application:  

WB, FC, ICC/IF

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-13342AS
CAS No.: 2468771-43-7
Purity:  92.56%
Synonyms: YN968D1-d8 free base
Apatinib-d8 (free base) is the deuterium labeled Apatinib free base . Apatinib free base (YN968D1 free base) is an orally bioavailable tyrosine kinase inhibitor, which selectively targets VEGFR-2 (IC50=1 nM). Apatinib free base (YN968D1 free base) is an anti-angiogenic drug for the research of advanced or metastatic gastric cancer. Apatinib free base (YN968D1 free base) potently inhibits Ret, c-Kit and c-Src with IC50s of 13, 429 and 530 nM, respectively. It also inhibits cellular phosphorylation of VEGFR-2, c-kit and PDGFRβ .
loading...
    loading...
Cat. No.: HY-170958
Target:  

Src Apoptosis

Research Areas:  

Cancer

Scr-IN-1 (Compound 4e) is a Tyrosine kinase inhibitor. Scr-IN-1 inhibits HCT-116 cells and MIA-PaCa-2 cells with IC50s of 0.16 μM and 1.16 μM, respectively. Scr-IN-1 displays selectivity profile on HCT-116 cells and MIA-PaCa-2 cells with SI > 625 and SI > 86, respectively. Scr-IN-1 induces Apoptosis in HCT-116 colon cancer cell and does not cause any change in the rate of necrotic cells. Scr-IN-1 is a novel SRC kinase inhibitor candidate for HCT-116 cells. Scr-IN-1 is potential for cancer research .
loading...
    loading...
Cat. No.: HY-P706066
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: LYN; Tyrosine-Protein Kinase Lyn; LYN Proto-Oncogene, SRC Family Tyrosine Kinase; P53Lyn; JTK8; P56Lyn; V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog; Tyrosine-Protein Kinase; Lck/Yes-Related Novel Protein Tyrosine Kinase; SAIDV
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-P811965A
Synonyms: CIN85, SH3KBP1, SH3 domain-containing kinase-binding protein 1, CD2-binding protein 3, Cbl-interacting protein of 85 kDa, Human SRC family kinase-binding protein 1, CD2BP3, HSB-1

Host:  

Mouse

Application:  

WB, FC, ICC/IF

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P701691
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HCK; P59-HCK/P60-HCK; HCK Proto-Oncogene, SRC Family Tyrosine Kinase; P59Hck; Hemopoietic Cell Kinase; P61Hck; JTK9; Tyrosine-Protein Kinase; Tyrosine-Protein Kinase HCK; AIPCV; Hematopoietic Cell Kinase
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-P706102
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: SRMS; PTK70; Prev. C20orf148; Tyrosine-Protein Kinase Srms; DJ697K14.1; Chromosome 20 Open Reading Frame 148; SRC-Related Kinase Lacking C-Terminal Regulatory Tyrosine And N-Terminal Myristylation Sites; SRM
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-123450
CAS No.: 1257628-57-1
Purity:  99.60%
Target:  

Bcr-Abl Apoptosis PDGFR

Research Areas:  

Cancer

S116836, a potent, orally active BCR-ABL tyrosine kinase inhibitor, blocks both wild-type as well as T315I Bcr-Abl. S116836 arrests the cells in the G0/G1 phase of cell cycle, induces apoptosis, increases ROS production, and decreases GSH production in BaF3/WT and BaF3/T315I cells. S116836 also inhibits SRC, LYN, HCK, LCK and BLK, and receptor tyrosine kinases such as FLT3, TIE2, KIT, PDGFR-β. Antitumor activies . S116836 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-124813
CAS No.: 2083618-79-3
Purity:  99.29%
Synonyms: 113B7
Target:  

FAK EGFR MMP NF-κB SDCBP

Research Areas:  

Cancer

PDZ1i (113B7) is a inhibitor of MDA-9/Syntenin, with selective binding to the PDZ1 domain. PDZ1i inhibits radiation-induced invasion of glioblastoma (GBM) cells, radiosensitizes GBM cells, and impairs GBM-related signaling pathways (including Src/EphA2, EGFRvIII/FAK, and NF-κB). PDZ1i reduces radiation-induced secretion of invasion-related proteases (MMP-2, MMP-9, ADAM9). PDZ1i shows anti-tumor effects in nude mice bearing intracranial U1242-luc xenografts or GBM xenografts. PDZ1i can be used for the study of glioblastoma (GBM), breast cancer and prostate cancer .
loading...
    loading...
Cat. No.: HY-P701692
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HCK; P59-HCK/P60-HCK; HCK Proto-Oncogene, SRC Family Tyrosine Kinase; P59Hck; Hemopoietic Cell Kinase; P61Hck; JTK9; Tyrosine-Protein Kinase; Tyrosine-Protein Kinase HCK; AIPCV; Hematopoietic Cell Kinase
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-P70396
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GRB2; Epididymis Secretory Sperm Binding Protein; Growth Factor Receptor Bound Protein 2; Growth Factor Receptor-Bound Protein 3; Growth Factor Receptor-Bound Protein 2; Abundant SRC Homology; SH2/SH3 Adapter GRB2; EGFRBP-GRB2; NCKAP2; MSTP084; Adapter Pr
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P75665
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: CDCP1; Subtractive Immunization M Plus HEp3-Associated 135 KDa Protein; CUB Domain Containing Protein 1; Transmembrane And Associated With SRC Kinases; SIMA135; Membrane Glycoprotein Gp140; CUB Domain-Containing Protein 1; TRASK; CD318; CD318 Antigen
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P77891
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: CDCP1; Subtractive Immunization M Plus HEp3-Associated 135 KDa Protein; CUB Domain Containing Protein 1; Transmembrane And Associated With SRC Kinases; SIMA135; Membrane Glycoprotein Gp140; CUB Domain-Containing Protein 1; TRASK; CD318; CD318 Antigen
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P77892
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: CDCP1; Subtractive Immunization M Plus HEp3-Associated 135 KDa Protein; CUB Domain Containing Protein 1; Transmembrane And Associated With SRC Kinases; SIMA135; Membrane Glycoprotein Gp140; CUB Domain-Containing Protein 1; TRASK; CD318; CD318 Antigen
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P78268
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: CDCP1; Subtractive Immunization M Plus HEp3-Associated 135 KDa Protein; CUB Domain Containing Protein 1; Transmembrane And Associated With SRC Kinases; SIMA135; Membrane Glycoprotein Gp140; CUB Domain-Containing Protein 1; TRASK; CD318; CD318 Antigen
Species:  
Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P700687
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: CDCP1; Subtractive Immunization M Plus HEp3-Associated 135 KDa Protein; CUB Domain Containing Protein 1; Transmembrane And Associated With SRC Kinases; SIMA135; Membrane Glycoprotein Gp140; CUB Domain-Containing Protein 1; TRASK; CD318; CD318 Antigen
Species:  
Rat
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-108486
CAS No.: 70563-58-5
Purity:  99%
Herbimycin A is an antibiotic and protein tyrosine kinase inhibitor. Herbimycin A directly inhibits the autophosphorylation of p210 BCR-ABL with an IC50 of approximately 5 μM, and reduces Src kinase activity. Herbimycin A also induces the degradation of receptor tyrosine kinases such as insulin-like growth factor 1 receptor (IGF-1R), insulin receptor (IR) and epidermal growth factor receptor (EGFR) via the ubiquitin-20S proteasome pathway. Herbimycin A directly modifies NF-κB p50, with the main target site involving Cys62, thereby blocking the DNA binding of p50 and NF-κB-driven gene expression. Herbimycin A can be used in studies related to tyrosine kinase signaling, chronic myeloid leukemia, NF-κB signaling, osteoclast function, apoptosis and cellular stress .
loading...
    loading...
Cat. No.: HY-158429
CAS No.: 2836297-26-6
Research Areas:  

Cancer

PROTAC CYP1B1 degrader-2 is a CYP1B1 PROTAC degrader with a DC50 of approximately 0.1 nM. PROTAC CYP1B1 degrader-2 induces ubiquitination and proteasomal degradation of CYP1B1, and forms a ternary complex with VHL ubiquitin ligase and CYP1B1. PROTAC CYP1B1 degrader-2 inhibits P-gp. PROTAC CYP1B1 degrader-2 inhibits FAK/SRC. PROTAC CYP1B1 degrader-2 exhibits anticancer activity against paclitaxel (HY-B0015)-resistant non-small cell lung cancer. PROTAC CYP1B1 degrader-2 can be used in studies related to non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-P70109
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CDCP1; Subtractive Immunization M Plus HEp3-Associated 135 KDa Protein; CUB Domain Containing Protein 1; Transmembrane And Associated With SRC Kinases; SIMA135; Membrane Glycoprotein Gp140; CUB Domain-Containing Protein 1; TRASK; CD318; CD318 Antigen
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P77625
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: CDCP1; Subtractive Immunization M Plus HEp3-Associated 135 KDa Protein; CUB Domain Containing Protein 1; Transmembrane And Associated With SRC Kinases; SIMA135; Membrane Glycoprotein Gp140; CUB Domain-Containing Protein 1; TRASK; CD318; CD318 Antigen
Species:  
Rhesus Macaque
Source:  
HEK293
loading...
    loading...